BIOMARIN PHARMACEUTICAL INC
BMRN
21 insider filings · Latest: Jun 2, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 7, 2026 | May 11 5:01 PM | Gregory R FribergEVP, Chief R&D Officer | Sale | 3,281 | $53.85 | $176.7K | 51,818(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 18 1:42 PM | Cristin HubbardEVP, Chief Commercial Officer | Grant/Award | 36,680 | $57.43 | 36,680(D) | View → |
| Mar 16, 2026 | Mar 18 1:39 PM | Gregory R FribergEVP, Chief R&D Officer | Grant/Award | 45,600 | $57.43 | 45,600(D) | View → |
| Mar 16, 2026 | Mar 17 8:50 PM | Charles Greg GuyerEVP, Chief Technical Officer | Grant/Award | 35,680 | $57.43 | 35,680(D) | View → |
| Mar 16, 2026 | Mar 17 8:48 PM | George Eric DavisEVP, Chief Legal Officer | Grant/Award | 34,690 | $57.43 | 34,690(D) | View → |
| Mar 16, 2026 | Mar 17 8:45 PM | Brian MuellerEVP, Chief Financial Officer | Grant/Award | 44,600 | $57.43 | 44,600(D) | View → |
| Mar 16, 2026 | Mar 17 8:43 PM | Alexander HardyDirector, Chief Executive Officer | Grant/Award | 89,200 | $57.43 | 89,200(D) | View → |